CLYM
Climb Bio
CLYM
CLYM
20 hedge funds and large institutions have $61M invested in Climb Bio in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$746K | |
| 2 | +$92.6K | |
| 3 | +$31.5K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$26.1K |
| 5 |
BlackRock
New York
|
+$1.22K |
Top Sellers
| 1 | -$732K | |
| 2 | -$37K | |
| 3 | -$17K | |
| 4 |
Millennium Management
New York
|
-$15.7K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$4.77K |